HC Wainwright & Co. Reiterates Neutral on Summit Therapeuticsto Neutral

Benzinga · 3d ago
HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates Summit Therapeutics (NASDAQ:SMMT) from Neutral to Neutral.